Immunosuppression for HCV following liver transplantation: Enough is just enough

Transplantation

Volumn 78, Issue 10, 2004, Pages 1413-1414

  McCaughan, G W ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

CLINICAL TRIAL; CORTICOSTEROID THERAPY; GRAFT REJECTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER FIBROSIS; LIVER TRANSPLANTATION; NOTE; OUTCOMES RESEARCH; PRIORITY JOURNAL; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; VIRUS REPLICATION;

ADRENAL CORTEX HORMONES; HEPATITIS C; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; RECURRENCE; REPRODUCIBILITY OF RESULTS;

EID: 9244252498     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000140976.61265.61     Document Type: Note

References (9)

1. Charlton M, Seaberg E for the National Institute of Diabetes and Digestive and Kidney diseases Liver Transplantation Database. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: Results of the National Institute of diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Liver Transpl Surg 1999; 5: S107.
2. Berenguer M, Crippin J, Gish R, et al. A model to predict severe HCV related disease following liver transplantation. Hepatology 2003; 38: 34.
3. Brillanti S, Vivarelli M, De Ruvo N, et al. Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation. Liver Transpl 2002; 8: 884.
4. European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection. Lancet 1994; 344: 423.
5. Charlton MR. Mycophenolate and hepatitis C: salve on a wound or gasoline on a fire? Liver Transpl 2002; 8: 47.
6. Wiesner R, Rabkin J, Klintmalam G, et al. A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients. Liver Transpl 2001; 422.
7. Filipponi F, Callea F, Salizzoni M, et al. Double-blind comparison of hepatitis C histological recurrence rate in HCV +liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporin and azathioprine. Transplantation 2004; 78: 1488.
8. Neuhaus P, Clavien PA, Kittur D, et al. Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial. Liver Transpl 2002; 8: 132.
9. Report of the first Internal Liver Transplantation Society expert panel consensus conference on liver transplantation on hepatitis C. Liver Transpl 2003; 9: S1.